Home > Healthcare > Biotechnology > Biotechnology R&D > Biopharmaceutical Fermentation Systems Market

Biopharmaceutical Fermentation Systems Market Size

  • Report ID: GMI9589
  • Published Date: May 2024
  • Report Format: PDF

A PHP Error was encountered

Severity: Warning

Message: getimagesize(iopharmaceutical Fermentation Systems Market Size</h2> <p>Biopharmaceutical Fermentation Systems Market size was valued at USD 11.5 billion in 2023 and is anticipated to showcase growth at 6% CAGR from 2024 and 2032. Growing demand for biopharmaceuticals, growing investments for developing new biopharmaceuticals and biosimilars, and increasing regulatory approvals for biopharmaceutical products is driving the demand for biopharmaceutical fermentation system market. Additionally, growing adoption of single use fermenters is also supporting the market growth.<br width=): failed to open stream: No such file or directory

Filename: v2_reports/body1.php

Line Number: 433

Backtrace:

File: /home/admin/web/gminsights.com/public_html/application/views/v2_reports/body1.php
Line: 433
Function: getimagesize

File: /home/admin/web/gminsights.com/public_html/application/views/v2_layouts/master_header_footer.php
Line: 1180
Function: view

File: /home/admin/web/gminsights.com/public_html/application/controllers/Reports.php
Line: 699
Function: view

File: /home/admin/web/gminsights.com/public_html/index.php
Line: 305
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: getimagesize(iopharmaceutical Fermentation Systems Market Size</h2> <p>Biopharmaceutical Fermentation Systems Market size was valued at USD 11.5 billion in 2023 and is anticipated to showcase growth at 6% CAGR from 2024 and 2032. Growing demand for biopharmaceuticals, growing investments for developing new biopharmaceuticals and biosimilars, and increasing regulatory approvals for biopharmaceutical products is driving the demand for biopharmaceutical fermentation system market. Additionally, growing adoption of single use fermenters is also supporting the market growth.<br width=): failed to open stream: No such file or directory

Filename: v2_reports/body1.php

Line Number: 433

Backtrace:

File: /home/admin/web/gminsights.com/public_html/application/views/v2_reports/body1.php
Line: 433
Function: getimagesize

File: /home/admin/web/gminsights.com/public_html/application/views/v2_layouts/master_header_footer.php
Line: 1180
Function: view

File: /home/admin/web/gminsights.com/public_html/application/controllers/Reports.php
Line: 699
Function: view

File: /home/admin/web/gminsights.com/public_html/index.php
Line: 305
Function: require_once

Biopharmaceutical Fermentation Systems Market Size

Biopharmaceutical Fermentation Systems Market size was valued at USD 11.5 billion in 2023 and is anticipated to showcase growth at 6% CAGR from 2024 and 2032. Growing demand for biopharmaceuticals, growing investments for developing new biopharmaceuticals and biosimilars, and increasing regulatory approvals for biopharmaceutical products is driving the demand for biopharmaceutical fermentation system market. Additionally, growing adoption of single use fermenters is also supporting the market growth.

 

Biopharmaceutical Fermentation Systems Market

Biopharmaceutical fermentation systems include the overall set of equipment, instruments, and procedures utilized for fermenting biological materials, such as microorganisms (such as bacteria, yeast, fungi) or cells (like mammalian or plant cells) to manufacture a diverse range of products. These systems can be complex or simple, based on the requirements and scale of the fermentation process.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The biopharmaceutical fermentation systems market size was valued at USD 11.5 billion in 2023 and is anticipated to grow at 6% CAGR from 2024 – 2032, owing to growing demand for biopharmaceuticals and hefty investments for developing new biopharmaceuticals.

The upstream products segment in the market held 62.2% share in 2023, driven by the increasing investments in biopharmaceutical research for the development of new and advanced therapies.

North America biopharmaceutical fermentation systems market accounted for 41.4% share in 2023 and is predicted to reach USD 7.7 billion by 2032, attributed to the presence of large number of biopharmaceutical companies offering advanced treatment options.

Agilent Technologies, Becton, Dickinson and Company, Bioengineering AG, Cellexus Limited, Danaher Corporation, Eppendorf AG, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Getinge Group, Lonza Group AG, Merck KGaA, Nova Biomedicals, Sartorius Stedim Biotech, Thermo Fisher Scientific Inc., and ZETA

Biopharmaceutical Fermentation Systems Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 214
  • Countries covered: 22
  • Pages: 123
 Download Free Sample